![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/519 | |
A61K 31/535 | |||
A61K 31/573 | |||
A61K 31/704 | |||
A61K 31/454 | |||
A61K 31/69 | |||
A61K 31/436 | |||
A61P 35/00 |
(11) | Number of the document | 2405916 |
(13) | Kind of document | T |
(96) | European patent application number | 10708866.8 |
Date of filing the European patent application | 2010-03-11 | |
(97) | Date of publication of the European application | 2012-01-18 |
(45) | Date of publication and mention of the grant of the patent | 2018-02-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2010/026903 |
Date | 2010-03-11 |
(87) | Number | WO 2010/105008 |
Date | 2010-09-16 |
(30) | Number | Date | Country code |
159622 P | 2009-03-12 | US |
(72) |
EBENS, Allen, J., Jr., US
FRIEDMAN, Lori, US
|
(73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
(54) | COMBINATIONS OF PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF HEMATOPOIETIC MALIGNANCIES |
COMBINATIONS OF PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF HEMATOPOIETIC MALIGNANCIES |